Texas Permanent School Fund’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-53,288
| Closed | -$22.3M | – | 1378 |
|
|
2024
Q1 | $22.3M | Buy |
53,288
+65
| +0.1% | +$27.5K | 0.18% | 86 |
|
|
2023
Q4 | $21.7M | Sell |
53,223
-125
| -0.2% | -$46.2K | 0.19% | 82 |
|
|
2023
Q3 | $18.6M | Sell |
53,348
-677
| -1% | -$237K | 0.18% | 87 |
|
|
2023
Q2 | $19M | Buy |
54,025
+426
| +0.8% | +$144K | 0.18% | 89 |
|
|
2023
Q1 | $16.9M | Buy |
53,599
+17,128
| +47% | +$5.14M | 0.17% | 97 |
|
|
2022
Q4 | $10.5M | Buy |
36,471
+184
| +0.5% | +$56.1K | 0.16% | 106 |
|
|
2022
Q3 | $10.5M | Buy |
36,287
+2,506
| +7% | +$721K | 0.17% | 88 |
|
|
2022
Q2 | $9.52M | Buy |
33,781
+760
| +2% | +$203K | 0.15% | 99 |
|
|
2022
Q1 | $8.62M | Sell |
33,021
-1,997
| -6% | -$474K | 0.12% | 135 |
|
|
2021
Q4 | $7.69M | Sell |
35,018
-5,060
| -13% | -$984K | 0.09% | 186 |
|
|
2021
Q3 | $7.27M | Sell |
40,078
-2,927
| -7% | -$571K | 0.09% | 192 |
|
|
2021
Q2 | $8.67M | Sell |
43,005
-404
| -0.9% | -$84.5K | 0.1% | 167 |
|
|
2021
Q1 | $9.33M | Sell |
43,409
-2,438
| -5% | -$536K | 0.12% | 140 |
|
|
2020
Q4 | $10.8M | Sell |
45,847
-3,118
| -6% | -$715K | 0.14% | 127 |
|
|
2020
Q3 | $13.3M | Buy |
48,965
+3,277
| +7% | +$904K | 0.18% | 82 |
|
|
2020
Q2 | $13.3M | Sell |
45,688
-1,011
| -2% | -$274K | 0.21% | 75 |
|
|
2020
Q1 | $11.1M | Buy |
46,699
+1,197
| +3% | +$275K | 0.2% | 79 |
|
|
2019
Q4 | $9.96M | Sell |
45,502
-2,377
| -5% | -$481K | 0.15% | 109 |
|
|
2019
Q3 | $8.11M | Sell |
47,879
-1,514
| -3% | -$268K | 0.13% | 140 |
|
|
2019
Q2 | $9.06M | Sell |
49,393
-343
| -0.7% | -$60K | 0.14% | 123 |
|
|
2019
Q1 | $9.15M | Sell |
49,736
-1,666
| -3% | -$308K | 0.15% | 117 |
|
|
2018
Q4 | $8.52M | Sell |
51,402
-5,968
| -10% | -$1.03M | 0.15% | 119 |
|
|
2018
Q3 | $11.1M | Sell |
57,370
-4,816
| -8% | -$858K | 0.15% | 114 |
|
|
2018
Q2 | $10.6M | Sell |
62,186
-3,415
| -5% | -$529K | 0.14% | 130 |
|
|
2018
Q1 | $10.7M | Sell |
65,601
-3,440
| -5% | -$562K | 0.14% | 131 |
|
|
2017
Q4 | $10.3M | Sell |
69,041
-829
| -1% | -$123K | 0.13% | 142 |
|
|
2017
Q3 | $10.6M | Sell |
69,870
-112
| -0.2% | -$16.9K | 0.14% | 136 |
|
|
2017
Q2 | $9.02M | Sell |
69,982
-2,608
| -4% | -$314K | 0.12% | 159 |
|
|
2017
Q1 | $7.94M | Sell |
72,590
-1,712
| -2% | -$151K | 0.1% | 183 |
|
|
2016
Q4 | $5.47M | Sell |
74,302
-2,005
| -3% | -$163K | 0.07% | 278 |
|
|
2016
Q3 | $6.66M | Sell |
76,307
-3,316
| -4% | -$313K | 0.09% | 222 |
|
|
2016
Q2 | $6.85M | Sell |
79,623
-4,788
| -6% | -$414K | 0.09% | 215 |
|
|
2016
Q1 | $6.71M | Sell |
84,411
-2,125
| -2% | -$192K | 0.08% | 235 |
|
|
2015
Q4 | $10.9M | Sell |
86,536
-706
| -0.8% | -$85.2K | 0.13% | 140 |
|
|
2015
Q3 | $9.09M | Sell |
87,242
-1,502
| -2% | -$193K | 0.12% | 162 |
|
|
2015
Q2 | $11M | Sell |
88,744
-1,888
| -2% | -$238K | 0.13% | 152 |
|
|
2015
Q1 | $10.7M | Sell |
90,632
-828
| -0.9% | -$99.2K | 0.12% | 165 |
|
|
2014
Q4 | $10.9M | Sell |
91,460
-1,006
| -1% | -$113K | 0.12% | 161 |
|
|
2014
Q3 | $10.4M | Sell |
92,466
-6,002
| -6% | -$571K | 0.12% | 162 |
|
|
2014
Q2 | $9.32M | Sell |
98,468
-4,998
| -5% | -$350K | 0.1% | 206 |
|
|
2014
Q1 | $7.32M | Sell |
103,466
-4,770
| -4% | -$378K | 0.08% | 275 |
|
|
2013
Q4 | $8.04M | Sell |
108,236
-7,595
| -7% | -$529K | 0.08% | 246 |
|
|
2013
Q3 | $8.78M | Sell |
115,831
-132,430
| -53% | -$10.5M | 0.09% | 221 |
|
|
2013
Q2 | $19.8M | Buy |
+248,261
| New | +$18.3M | 0.21% | 88 |
|
Other funds holding VRTX
Texas Permanent School Fund's VRTX Position: Q2 2024 in Review
Texas Permanent School Fund sold out of Vertex Pharmaceuticals (VRTX) in Q2 2024, closing a stake of 53,288 shares — an estimated $22.3M sold.
Texas Permanent School Fund first reported a position in VRTX in Q2 2013 and held it in 44 quarters. The position peaked at $22.3M in Q1 2024. 1,546 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.
- Texas Permanent School Fund reported no remaining Vertex Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Texas Permanent School Fund sold 53,288 Vertex Pharmaceuticals shares in Q2 2024, an estimated $22.3M.
- Texas Permanent School Fund first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 44 quarters.
- Texas Permanent School Fund's Vertex Pharmaceuticals position peaked at $22.3M in Q1 2024.
- 1,546 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.
Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.